(Q36212638)

English

Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

interstitial lung disease

1 reference

based on heuristic

inferred from title

author name string

Arthur C Theodore

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Chi-Hong Tseng

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Ning Li

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Robert M Elashoff

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Donald P Tashkin

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 September 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

142

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

614-621

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Isolated diffuse ground-glass opacity in thoracic CT: causes and clinical presentations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

1 October 2017

Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

29 June 2018

Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

29 June 2018

Adverse events during the Scleroderma Lung Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

22 September 2018

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

22 September 2018

Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

22 September 2018

Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

22 September 2018

The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3435135

22 September 2018

Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of lung stretch receptors on the cough reflex in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Traction bronchiectasis in end-stage pulmonary fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High resolution computed tomography in early scleroderma lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of capsaicin-sensitive C-fibre afferent nerves in the cough reflex

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Afferent receptors in the airways and cough

1 reference

https://pubmed.ncbi.nlm.nih.gov/22156609

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1378/CHEST.11-0801

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36212638&oldid=1621492742"